📰 3 sources covering this story

Treatment for Friedreich's ataxia should not be funded by HSE, drugs group recommends

First covered 13 hrs ago · latest take 2 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Treatment for Friedreich's ataxia should not be funded by HSE, drugs group recommends
TheJournal.ie
TheJournal.ie2 hrs ago
Treatment for Friedreich's ataxia should not be funded by HSE, drugs group recommends
The HSE Drugs Group made the recommendation following a meeting to consider an application for the reimbursement of Skyclarys.
Sufferers of Friedreich’s Ataxia face major setback as HSE Drugs Group rejects Skyclarys reimbursement
There is still hope as the recommendation will have to go before a meeting of HSE senior management on August 25 for a final decision
RTÉ News
RTÉ News🏁 first to report13 hrs ago
HSE recommends not covering Friedreich's Ataxia drug cost
The HSE Drugs Group has decided to recommend that the drug Skyclarys, for Friedreich's Ataxia, should not be covered by the HSE.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →